Therapeutic Advances in Respiratory Disease
@tarespirdis.bsky.social
Respiratory Disease | Impact Factor 3.0 | Indexed in: SCIE, MEDLINE, PMC, Scopus, DOAJ, ProQuest | Published by Sage Journals | #OpenAccess
The complexity of managing a patient with CTD-PAH can be dizzying. 😵💫
Our latest paper breaks down the management of these patients into practical pieces.
journals.sagepub.com/doi/10.1177/...
Our latest paper breaks down the management of these patients into practical pieces.
journals.sagepub.com/doi/10.1177/...
CTD-PAH: an updated practical approach to screening, diagnosis, and management - Noura Alturaif, Fatima K. Alduraibi, 2025
Connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) is a progressive and high-risk subtype of PAH, with outcomes generally worse than...
journals.sagepub.com
October 24, 2025 at 11:52 AM
The complexity of managing a patient with CTD-PAH can be dizzying. 😵💫
Our latest paper breaks down the management of these patients into practical pieces.
journals.sagepub.com/doi/10.1177/...
Our latest paper breaks down the management of these patients into practical pieces.
journals.sagepub.com/doi/10.1177/...
Reposted by Therapeutic Advances in Respiratory Disease
Next-generation radiomic sequencing in non-small cell lung cancer: an alternative model to predict mutations from [18F]FDG PET/CT
@tarespirdis.bsky.social
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#NSCLC #radiomics #medicalimaging #precisiononcology #openaccess
@tarespirdis.bsky.social
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#NSCLC #radiomics #medicalimaging #precisiononcology #openaccess
October 17, 2025 at 6:44 PM
Next-generation radiomic sequencing in non-small cell lung cancer: an alternative model to predict mutations from [18F]FDG PET/CT
@tarespirdis.bsky.social
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#NSCLC #radiomics #medicalimaging #precisiononcology #openaccess
@tarespirdis.bsky.social
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#NSCLC #radiomics #medicalimaging #precisiononcology #openaccess
Lungs on fire 🔥 - the ERS session on respiratory infections is about to kick off. Looking forward to insights from Associate Editor Tom Wilkinson, who's joining as a discussant. #ERSCongress2025 #ERS2025 #RespiratoryHealth
September 30, 2025 at 1:26 PM
Lungs on fire 🔥 - the ERS session on respiratory infections is about to kick off. Looking forward to insights from Associate Editor Tom Wilkinson, who's joining as a discussant. #ERSCongress2025 #ERS2025 #RespiratoryHealth
Later today Associate Editor Corrado Pelaia is chairing a session at #ERS2025: Remission/stability in airway diseases – how to achieve it and what’s next?
Exploring strategies for long-term disease control and emerging research.
#ERSCongress2025 #AirwayDiseases
Exploring strategies for long-term disease control and emerging research.
#ERSCongress2025 #AirwayDiseases
September 30, 2025 at 9:41 AM
Later today Associate Editor Corrado Pelaia is chairing a session at #ERS2025: Remission/stability in airway diseases – how to achieve it and what’s next?
Exploring strategies for long-term disease control and emerging research.
#ERSCongress2025 #AirwayDiseases
Exploring strategies for long-term disease control and emerging research.
#ERSCongress2025 #AirwayDiseases
At #ERS2025, Associate Editor Dr Shaney Barratt chaired a poster session on Clinical prognostication in pulmonary fibrosis.
The session highlighted current approaches and future directions in predicting disease progression.
#ERSCongress2025 #PulmonaryFibrosis
The session highlighted current approaches and future directions in predicting disease progression.
#ERSCongress2025 #PulmonaryFibrosis
September 30, 2025 at 8:56 AM
At #ERS2025, Associate Editor Dr Shaney Barratt chaired a poster session on Clinical prognostication in pulmonary fibrosis.
The session highlighted current approaches and future directions in predicting disease progression.
#ERSCongress2025 #PulmonaryFibrosis
The session highlighted current approaches and future directions in predicting disease progression.
#ERSCongress2025 #PulmonaryFibrosis
Great to connect with Editor-in-Chief Dr. Nazia Chaudhuri and several Associate Editors of Therapeutic Advances in Respiratory Disease at #ERSCongress2025 yesterday. Valuable discussions around editorial priorities and future plans!
#ERS2025 #RespiratoryDisease
@ild-ipfdoc.bsky.social
#ERS2025 #RespiratoryDisease
@ild-ipfdoc.bsky.social
September 30, 2025 at 8:14 AM
Great to connect with Editor-in-Chief Dr. Nazia Chaudhuri and several Associate Editors of Therapeutic Advances in Respiratory Disease at #ERSCongress2025 yesterday. Valuable discussions around editorial priorities and future plans!
#ERS2025 #RespiratoryDisease
@ild-ipfdoc.bsky.social
#ERS2025 #RespiratoryDisease
@ild-ipfdoc.bsky.social
🔥 Lungs on Fire: Interstitial Lung Diseases is now live at #ERS2025 - a packed session co-chaired by our Editor-in-Chief, Dr Nazia Chaudhuri.
#ERSCongress
#ERSCongress
September 29, 2025 at 8:59 AM
🔥 Lungs on Fire: Interstitial Lung Diseases is now live at #ERS2025 - a packed session co-chaired by our Editor-in-Chief, Dr Nazia Chaudhuri.
#ERSCongress
#ERSCongress
📣Just published: a plain language summary of publication exploring how doctors and patients communicate about treatment for systemic sclerosis-associated interstitial lung disease.
👉Read it here: journals.sagepub.com/doi/full/10....
#SSc #ILD
👉Read it here: journals.sagepub.com/doi/full/10....
#SSc #ILD
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
journals.sagepub.com
September 29, 2025 at 7:30 AM
📣Just published: a plain language summary of publication exploring how doctors and patients communicate about treatment for systemic sclerosis-associated interstitial lung disease.
👉Read it here: journals.sagepub.com/doi/full/10....
#SSc #ILD
👉Read it here: journals.sagepub.com/doi/full/10....
#SSc #ILD
It's our second day at #ERS2025! Today’s programme includes sessions chaired by our Associate Editors and Editor-in-Chief.
Looking forward to the discussions ahead. #ERSCongress
Looking forward to the discussions ahead. #ERSCongress
September 29, 2025 at 7:17 AM
It's our second day at #ERS2025! Today’s programme includes sessions chaired by our Associate Editors and Editor-in-Chief.
Looking forward to the discussions ahead. #ERSCongress
Looking forward to the discussions ahead. #ERSCongress
📢About to begin: ALERT 2 – Infections, Lung Cancer and Respiratory Symptoms Management
Chaired by our Associate Editor Tom Wilkinson, with editorial board member Francesco Blasi joining as a discussant. Looking forward to catching some of the insights!🫁
#ERSCongress2025
Chaired by our Associate Editor Tom Wilkinson, with editorial board member Francesco Blasi joining as a discussant. Looking forward to catching some of the insights!🫁
#ERSCongress2025
September 28, 2025 at 1:26 PM
📢About to begin: ALERT 2 – Infections, Lung Cancer and Respiratory Symptoms Management
Chaired by our Associate Editor Tom Wilkinson, with editorial board member Francesco Blasi joining as a discussant. Looking forward to catching some of the insights!🫁
#ERSCongress2025
Chaired by our Associate Editor Tom Wilkinson, with editorial board member Francesco Blasi joining as a discussant. Looking forward to catching some of the insights!🫁
#ERSCongress2025
Enjoyed the session on Emerging Clinical Trials in Pulmonary Fibrosis, co-chaired by our Editor-in-Chief Dr. Nazia Chaudhuri.
A popular and timely discussion with lots of interest from attendees.
#ERS2025 #ERSCongress2025 #ClinicalTrials
A popular and timely discussion with lots of interest from attendees.
#ERS2025 #ERSCongress2025 #ClinicalTrials
September 28, 2025 at 10:17 AM
Enjoyed the session on Emerging Clinical Trials in Pulmonary Fibrosis, co-chaired by our Editor-in-Chief Dr. Nazia Chaudhuri.
A popular and timely discussion with lots of interest from attendees.
#ERS2025 #ERSCongress2025 #ClinicalTrials
A popular and timely discussion with lots of interest from attendees.
#ERS2025 #ERSCongress2025 #ClinicalTrials
Great turnout at ALERT 1: Obstructive Airway Diseases in Children and Adults, with our Associate Editor Prof Antonio Spanevello contributing as a discussant.
Engaging presentations and valuable discussion made this a great session🫁 #ERS2025 #RespiratoryMedicine #ERSCongress
Engaging presentations and valuable discussion made this a great session🫁 #ERS2025 #RespiratoryMedicine #ERSCongress
September 28, 2025 at 8:35 AM
Great turnout at ALERT 1: Obstructive Airway Diseases in Children and Adults, with our Associate Editor Prof Antonio Spanevello contributing as a discussant.
Engaging presentations and valuable discussion made this a great session🫁 #ERS2025 #RespiratoryMedicine #ERSCongress
Engaging presentations and valuable discussion made this a great session🫁 #ERS2025 #RespiratoryMedicine #ERSCongress
Excited to be at #ERSCongress today!
Looking forward to sharing highlights from sessions and posters - including some fantastic contributions from our board. Stay tuned for updates throughout the day 🫁✨ #ERS2025 #RespiratoryMedicine
Looking forward to sharing highlights from sessions and posters - including some fantastic contributions from our board. Stay tuned for updates throughout the day 🫁✨ #ERS2025 #RespiratoryMedicine
September 28, 2025 at 5:54 AM
Excited to be at #ERSCongress today!
Looking forward to sharing highlights from sessions and posters - including some fantastic contributions from our board. Stay tuned for updates throughout the day 🫁✨ #ERS2025 #RespiratoryMedicine
Looking forward to sharing highlights from sessions and posters - including some fantastic contributions from our board. Stay tuned for updates throughout the day 🫁✨ #ERS2025 #RespiratoryMedicine
📍 Heading to Amsterdam for #ERSCongress this week!
Looking forward to connecting with our Editorial Board Members and engaging with the latest developments in respiratory research. If you're attending, feel free to get in touch!
Follow along for updates from the congress! 🫁
Looking forward to connecting with our Editorial Board Members and engaging with the latest developments in respiratory research. If you're attending, feel free to get in touch!
Follow along for updates from the congress! 🫁
September 22, 2025 at 4:14 PM
📍 Heading to Amsterdam for #ERSCongress this week!
Looking forward to connecting with our Editorial Board Members and engaging with the latest developments in respiratory research. If you're attending, feel free to get in touch!
Follow along for updates from the congress! 🫁
Looking forward to connecting with our Editorial Board Members and engaging with the latest developments in respiratory research. If you're attending, feel free to get in touch!
Follow along for updates from the congress! 🫁
Reposted by Therapeutic Advances in Respiratory Disease
The correlation between the level of therapy adherence and inhalation technique in children with uncontrolled asthma using a smart inhaler: the IMAGINE study
@tarespirdis.bsky.social
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#ehealth #pediatric #medicine #medsky #openaccess
@tarespirdis.bsky.social
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#ehealth #pediatric #medicine #medsky #openaccess
June 20, 2025 at 7:20 PM
The correlation between the level of therapy adherence and inhalation technique in children with uncontrolled asthma using a smart inhaler: the IMAGINE study
@tarespirdis.bsky.social
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#ehealth #pediatric #medicine #medsky #openaccess
@tarespirdis.bsky.social
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#ehealth #pediatric #medicine #medsky #openaccess
Reposted by Therapeutic Advances in Respiratory Disease
Efficacy of respiratory muscle training in improving pulmonary function and survival in patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis
@tarespirdis.bsky.social @journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#ALS #neuromuscular #healthcare #openaccess
@tarespirdis.bsky.social @journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#ALS #neuromuscular #healthcare #openaccess
June 20, 2025 at 7:25 PM
Efficacy of respiratory muscle training in improving pulmonary function and survival in patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis
@tarespirdis.bsky.social @journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#ALS #neuromuscular #healthcare #openaccess
@tarespirdis.bsky.social @journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#ALS #neuromuscular #healthcare #openaccess
Reposted by Therapeutic Advances in Respiratory Disease
Therapeutic options for patients with pulmonary hypertension and interstitial lung disease
@tarespirdis.bsky.social
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#respiratorydisease #treatment #medicine #medsky #openaccess
@tarespirdis.bsky.social
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#respiratorydisease #treatment #medicine #medsky #openaccess
June 27, 2025 at 6:53 PM
Therapeutic options for patients with pulmonary hypertension and interstitial lung disease
@tarespirdis.bsky.social
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#respiratorydisease #treatment #medicine #medsky #openaccess
@tarespirdis.bsky.social
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#respiratorydisease #treatment #medicine #medsky #openaccess
Reposted by Therapeutic Advances in Respiratory Disease
Advances in diagnosis and patient profiling in pulmonary arterial hypertension for precision medicine
@tarespirdis.bsky.social
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#artificialintelligence #genetictesting #medsky #lungdisease #openaccess
@tarespirdis.bsky.social
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#artificialintelligence #genetictesting #medsky #lungdisease #openaccess
September 12, 2025 at 6:23 PM
Advances in diagnosis and patient profiling in pulmonary arterial hypertension for precision medicine
@tarespirdis.bsky.social
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#artificialintelligence #genetictesting #medsky #lungdisease #openaccess
@tarespirdis.bsky.social
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#artificialintelligence #genetictesting #medsky #lungdisease #openaccess
Immunosuppression is a core part of managing interstitial lung diseases. Learn how outcomes differ between antisynthetase syndrome and systemic sclerosis in response to treatment!
journals.sagepub.com/doi/full/10....
journals.sagepub.com/doi/full/10....
May 9, 2025 at 10:20 AM
Immunosuppression is a core part of managing interstitial lung diseases. Learn how outcomes differ between antisynthetase syndrome and systemic sclerosis in response to treatment!
journals.sagepub.com/doi/full/10....
journals.sagepub.com/doi/full/10....
Don't lose the forest for the trees! Check out this forest plot in our latest meta-analysis on cardiovascular risk in patients with asthma!
journals.sagepub.com/doi/10.1177/...
journals.sagepub.com/doi/10.1177/...
May 9, 2025 at 10:18 AM
Don't lose the forest for the trees! Check out this forest plot in our latest meta-analysis on cardiovascular risk in patients with asthma!
journals.sagepub.com/doi/10.1177/...
journals.sagepub.com/doi/10.1177/...
🔥Hot off the press! Glucocorticoids are a cornerstone of therapy for many respiratory conditions. However, there are unintended effects. Here's a comprehensive review of the impact of cumulative glucocorticoid dosage in immunocompromised patients.
journals.sagepub.com/doi/10.1177/...
journals.sagepub.com/doi/10.1177/...
April 22, 2025 at 9:13 AM
🔥Hot off the press! Glucocorticoids are a cornerstone of therapy for many respiratory conditions. However, there are unintended effects. Here's a comprehensive review of the impact of cumulative glucocorticoid dosage in immunocompromised patients.
journals.sagepub.com/doi/10.1177/...
journals.sagepub.com/doi/10.1177/...
Severe asthma is a deadly disease ☠️
Read the latest review on inhaled triple therapy in patients with severe asthma!
journals.sagepub.com/doi/10.1177/...
Read the latest review on inhaled triple therapy in patients with severe asthma!
journals.sagepub.com/doi/10.1177/...
April 15, 2025 at 3:32 PM
Severe asthma is a deadly disease ☠️
Read the latest review on inhaled triple therapy in patients with severe asthma!
journals.sagepub.com/doi/10.1177/...
Read the latest review on inhaled triple therapy in patients with severe asthma!
journals.sagepub.com/doi/10.1177/...
April is Sarcoidosis Awareness Month. Throwback to our paper on the management of sarcoidosis.
journals.sagepub.com/doi/full/10....
journals.sagepub.com/doi/full/10....
April 7, 2025 at 4:23 PM
April is Sarcoidosis Awareness Month. Throwback to our paper on the management of sarcoidosis.
journals.sagepub.com/doi/full/10....
journals.sagepub.com/doi/full/10....
From targeted therapy to multidisciplinary management, Cystic Fibrosis has outlined a standard model for research and management of complex respiratory diseases. Please check out our latest review!
journals.sagepub.com/doi/10.1177/...
journals.sagepub.com/doi/10.1177/...
April 7, 2025 at 4:23 PM
From targeted therapy to multidisciplinary management, Cystic Fibrosis has outlined a standard model for research and management of complex respiratory diseases. Please check out our latest review!
journals.sagepub.com/doi/10.1177/...
journals.sagepub.com/doi/10.1177/...